On October 17, 2019 Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI;OTCQX:NRIFF), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, reported it intends to release its third quarter 2019 financial results before markets open on Thursday, October 31, 2019 (Press release, Nuvo Pharmaceuticals, OCT 17, 2019, View Source [SID1234542346]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The Company will subsequently hold a conference call that same day, Thursday, October 31, 2019 at 8:30 a.m. ET, hosted by Jesse Ledger, Nuvo’s President & Chief Executive Officer and other senior management. A question-and-answer session will follow the corporate update.
CONFERENCE CALL DETAILS
DATE:
Thursday, October 31, 2019
TIME:
8:30 a.m. ET
DIAL-IN NUMBER:
416 764 8688 or 1 888 390 0546
TAPED REPLAY:
416 764 8677 or 1 888 390 0541 / REPLAY PASSCODE: 072242 #
The audio webcast can be accessed at: